{"ModuleTitle": "Company Description", "CompanyName": "Bio-Techne Corp", "Symbol": "TECH", "Address": "614 MCKINLEY PL N E, MINNEAPOLIS, Minnesota, 55413, United States of America", "Phone": "6123798854", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Bio-Techne and its subsidiaries, collectively doing business as Bio-Techne\r\nCorporation (Bio-Techne, we, our, us or the Company), develop, manufacture and\r\nsell life science reagents, instruments and services for the research and\r\nclinical diagnostic markets worldwide. With our deep product portfolio and\r\napplication expertise, we sell integral components of scientific investigations\r\ninto biological processes and molecular diagnostics, revealing the nature,\r\ndiagnosis, etiology and progression of specific diseases. Our products aid in\r\ndrug discovery efforts and provide the means for accurate clinical tests and\r\ndiagnoses.\r\n\r\n \r\n\r\nDuring our fiscal year 2019, we operated with two reporting segments - our\r\nProtein Sciences segment and our Diagnostics and Genomics segment.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2019%2f08%2f28%2f0001437749-19-017565.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Charles R. Kummeth", "title": "President, Chief Executive Officer & Director"}, {"name": "James T. Hippel", "title": "CFO & Principal Accounting Officer"}, {"name": "Robert Monroe", "title": "Chief Medical Officer"}], "Number_of_employees": ["2,100"], "Subsidiaries": ["NO INFO"]}